Approved and Experimental Therapies for Idiopathic Pulmonary Fibrosis-Reference-Cited by-同舟云学术

Approved and Experimental Therapies for Idiopathic Pulmonary Fibrosis

Published:2018-10-29 Issue:4 Volume:7 Page:107-117
ISSN:2199-2428
Container-title:Current Pulmonology Reports
language:en
Short-container-title:Curr Pulmonol Rep

Author:

Pasciuto Giuliana,Inchingolo Riccardo,Condoluci Carola,Magnini Daniele,Iovene Bruno,Richeldi Luca

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

http://link.springer.com/article/10.1007/s13665-018-0209-0/fulltext.html

Reference94 articles.

1. • Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198:e44–68 This international, evidence-based guideline provides an update on the diagnosis of IPF.

2. Idiopathic Pulmonary Fibrosis Clinical Research Network, Raghu G, Anstrom KJ, King TE, Lasky JA, Martinez FJ. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012;366:1968–77.

3. • Raghu G, Rochwerg B, Zhang Y, Garcia CAC, Azuma A, Behr J, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis: an update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192:e3–e19 This guideline provides recommendations for or against specific agents based on literature evidences; nintedanid and pirfenidone received for the first time a conditional recommandation for the treatment in IPF patients.

4. Conte E, Gili E, Fagone E, Fruciano M, Iemmolo M, Vancheri C. Effect of pirfenidone on proliferation, TGF-B-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts. Eur J Pharm Sci. 2014;58:13–9.

5. Iyer SN, Gurujeyalakshmi G, Giri SN. Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. J Pharmacol Exp Ther. 1999;291:367–73.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potent and Selective Human Prostaglandin F (FP) Receptor Antagonist (BAY-6672) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF);Journal of Medicinal Chemistry;2020-09-24

2. Lipids - two sides of the same coin in lung fibrosis;Cellular Signalling;2019-08